Facts and ideas from anywhere.
作者信息
Roberts William Clifford
出版信息
Proc (Bayl Univ Med Cent). 2017 Jul;30(3):384-390. doi: 10.1080/08998280.2017.11929658.
Abstract
摘要
相似文献
1
Facts and ideas from anywhere.来自任何地方的事实与观点。
Proc (Bayl Univ Med Cent). 2017 Jul;30(3):384-390. doi: 10.1080/08998280.2017.11929658.
2
Facts and ideas from anywhere.来自任何地方的事实与观点。
Proc (Bayl Univ Med Cent). 2005 Apr;18(2):188-95. doi: 10.1080/08998280.2005.11928065.
3
Facts and ideas from anywhere.来自任何地方的事实和观点。
Proc (Bayl Univ Med Cent). 2015 Jan;28(1):126-33. doi: 10.1080/08998280.2015.11929211.
4
Facts and ideas from anywhere.来自任何地方的事实和观点。
Proc (Bayl Univ Med Cent). 2014 Oct;27(4):383-92. doi: 10.1080/08998280.2014.11929167.
5
Facts and ideas from anywhere.来自任何地方的事实和观点。
Proc (Bayl Univ Med Cent). 2002 Jan;15(1):107-18. doi: 10.1080/08998280.2002.11927824.
6
Facts and ideas from anywhere.来自任何地方的事实与观点。
Proc (Bayl Univ Med Cent). 2002 Apr;15(2):237-40. doi: 10.1080/08998280.2002.11927846.
7
Facts and ideas from anywhere.来自任何地方的事实和观点。
Proc (Bayl Univ Med Cent). 2002 Jul;15(3):339-46. doi: 10.1080/08998280.2002.11927863.
8
Facts and ideas from anywhere.来自任何地方的事实和想法。
Proc (Bayl Univ Med Cent). 2003 Jul;16(3):363-72. doi: 10.1080/08998280.2003.11927930.
9
Facts and ideas from anywhere.来自任何地方的事实和观点。
Proc (Bayl Univ Med Cent). 2001 Jan;14(1):117-22. doi: 10.1080/08998280.2001.11927745.
10
Facts and ideas from anywhere.来自任何地方的事实和想法。
Proc (Bayl Univ Med Cent). 2001 Apr;14(2):199-208. doi: 10.1080/08998280.2001.11927765.
引用本文的文献
1
Facts and ideas.事实与观点。
Proc (Bayl Univ Med Cent). 2017 Oct;30(4):418. doi: 10.1080/08998280.2017.11930211.
本文引用的文献
1
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病。1. 来自遗传、流行病学和临床研究的证据。欧洲动脉粥样硬化学会共识小组的共识声明。
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
2
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.实现极低水平低密度脂蛋白胆固醇的长期安全性和疗效：来自 IMPROVE-IT 试验的预设分析。
JAMA Cardiol. 2017 May 1;2(5):547-555. doi: 10.1001/jamacardio.2017.0083.
3
It's the cholesterol, stupid!是胆固醇，笨蛋！
Am J Cardiol. 2010 Nov 1;106(9):1364-6. doi: 10.1016/j.amjcard.2010.09.022.
4
Evaluating lipid-lowering trials in the twenty-first century.评估21世纪的降脂试验。
Am J Cardiol. 2009 May 1;103(9):1325-8. doi: 10.1016/j.amjcard.2009.02.008.
5
The cause of atherosclerosis.
Nutr Clin Pract. 2008 Oct-Nov;23(5):464-7. doi: 10.1177/0884533608324586.
6
Atherosclerosis: its cause and its prevention.动脉粥样硬化：其成因与预防
Am J Cardiol. 2006 Dec 1;98(11):1550-5. doi: 10.1016/j.amjcard.2006.10.005. Epub 2006 Oct 27.
7
Twenty questions on atherosclerosis.关于动脉粥样硬化的二十个问题。
Proc (Bayl Univ Med Cent). 2000 Apr;13(2):139-43. doi: 10.1080/08998280.2000.11927657.
8
Getting more people on statins.
Am J Cardiol. 2002 Sep 15;90(6):683-5. doi: 10.1016/s0002-9149(02)02590-0.
9
Shifting from decreasing risk to actually preventing and arresting atherosclerosis.从降低风险转向实际预防和阻止动脉粥样硬化。
Am J Cardiol. 1999 Mar 1;83(5):816-7. doi: 10.1016/s0002-9149(98)01078-9.
10
The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.他汀类药物降脂的“5规则”和“7规则”
Am J Cardiol. 1997 Jul 1;80(1):106-7.
Zotero 插件